Recent ALGS News
- Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024 • GlobeNewswire Inc. • 04/09/2024 12:00:00 PM
- Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies • GlobeNewswire Inc. • 03/27/2024 12:00:00 PM
- Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/12/2024 08:05:00 PM
- Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024 • GlobeNewswire Inc. • 03/05/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:44:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:42:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 10:35:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 10:33:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 10:31:16 PM
- Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024 • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Aligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024 • GlobeNewswire Inc. • 02/20/2024 01:00:00 PM
- Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments • GlobeNewswire Inc. • 02/13/2024 01:00:00 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 01/30/2024 12:04:23 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 01/25/2024 11:12:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 11:06:59 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/28/2023 09:01:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:05:32 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/17/2023 09:38:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:01:52 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 11/07/2023 05:03:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 08:23:34 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 11/02/2023 08:08:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:05:23 PM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM